Report overview
This report contains market size and forecasts of Thiotepa Injection in global, including the following market information:
Global Thiotepa Injection Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Thiotepa Injection Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Thiotepa Injection companies in 2022 (%)
The global Thiotepa Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
15 mg/vial Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Thiotepa Injection include ESTEVE, Adienne, Amneal Pharmaceuticals, MSN GROUP, Hikma, DR REDDYS and Hengrui, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Thiotepa Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thiotepa Injection Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Thiotepa Injection Market Segment Percentages, by Type, 2022 (%)
15 mg/vial
100 mg/vial
Global Thiotepa Injection Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Thiotepa Injection Market Segment Percentages, by Application, 2022 (%)
Pre-orphan Drug for Hematopoietic Stem Cell Transplantation (HPCT)
Anticancer Drugs
Others
Global Thiotepa Injection Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Thiotepa Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thiotepa Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Thiotepa Injection revenues share in global market, 2022 (%)
Key companies Thiotepa Injection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Thiotepa Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ESTEVE
Adienne
Amneal Pharmaceuticals
MSN GROUP
Hikma
DR REDDYS
Hengrui
